Target intelligence / Profile preview

Pseudogene, similar to general transcription factor IIi GTF2I

Molecular classification
Other (pseudogene)
01

Overview

This entry refers to a **pseudogene**—a non-functional DNA sequence that shares similarity with the *general transcription factor IIi* gene (*GTF2I*), which encodes a multifunctional transcription factor involved in regulating gene expression and cellular processes. However, as a pseudogene, ENSG00000281896 does not produce a functional protein and has no direct role in biological activity, disease, or pharmacological targeting[1].

Other names
ENSG00000281896

Beyond the preview

Go deeper on Pseudogene, similar to general transcription factor IIi GTF2I.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene, similar to general transcription factor IIi GTF2I.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call